MLH1 - 暇つぶしWikipedia

MLH1

□記事を途中から表示しています
[最初から表示]

出典[ソースを編集]^ a b c ⇒GRCm38: Ensembl release 89: ENSMUSG00000032498 - Ensembl, May 2017
^ .mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation.cs-ja1 q,.mw-parser-output .citation.cs-ja2 q{quotes:"「""」""『""』"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}Human PubMed Reference:
^ Mouse PubMed Reference:
^ “Entrez Gene: MLH1 mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli)”. 2020年10月18日閲覧。
^ Nikiforova, Marina N.; Nikiforov, Yuri E. (2011) (英語). Diagnostic Immunohistochemistry. Elsevier. pp. 42?57. doi:10.1016/b978-1-4160-5766-6.00006-6. ISBN 978-1-4160-5766-6. https://linkinghub.elsevier.com/retrieve/pii/B9781416057666000066
^ a b c “A review of the clinical relevance of mismatch-repair deficiency in ovarian cancer”. Cancer 113 (4): 733?42. (2008). doi:10.1002/cncr.23601. PMC 2644411. PMID 18543306. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2644411/.
^ a b “Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer”. Gastroenterology 128 (5): 1160?71. (2005). doi:10.1053/j.gastro.2005.01.056. PMID 15887099.
^ “Exonuclease 1-dependent and independent mismatch repair”. DNA Repair (Amst.) 32: 24?32. (2015). doi:10.1016/j.dnarep.2015.04.010. PMC 4522362. PMID 25956862. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522362/.
^ “Mechanisms and functions of DNA mismatch repair”. Cell Res. 18 (1): 85?98. (2008). doi:10.1038/cr.2007.115. PMID 18157157.
^ “New insights and challenges in mismatch repair: getting over the chromatin hurdle”. DNA Repair (Amst.) 19: 48?54. (2014). doi:10.1016/j.dnarep.2014.03.027. PMC 4127414. PMID 24767944. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127414/.
^ “CpG island methylation of the MLH1, MGMT, DAPK, and CASP8 genes in cancerous and adjacent noncancerous stomach tissues”. Medicina (Kaunas) 49 (8): 361?6. (2013). PMID 24509146.
^ “Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia”. Am. J. Pathol. 161 (2): 399?403. (2002). doi:10.1016/S0002-9440(10)64195-8. PMC 1850716. PMID 12163364. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1850716/.
^ “Frequent hypermethylation of the hMLH1 gene promoter in differentiated-type tumors of the stomach with the gastric foveolar phenotype”. Am. J. Pathol. 157 (3): 717?22. (2000). doi:10.1016/S0002-9440(10)64584-1. PMC 1949419. PMID 10980110. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1949419/.
^ “Promoter methylation status of DNA repair gene (hMLH1) in gastric carcinoma patients of the Kashmir valley”. Asian Pac. J. Cancer Prev. 13 (8): 4177?81. (2012). doi:10.7314/apjcp.2012.13.8.4177. PMID 23098428.
^ “Expression characteristics of FHIT, p53, BRCA2 and MLH1 in families with a history of oesophageal cancer in a region with a high incidence of oesophageal cancer”. Oncol Lett 9 (1): 430?436. (2015). doi:10.3892/ol.2014.2682. PMC 4246613. PMID 25436004. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246613/.
^ “Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene”. Am J Otolaryngol 32 (6): 528?36. (2011). doi:10.1016/j.amjoto.2010.11.005. PMID 21353335.
^ “Increased microsatellite instability and epigenetic inactivation of the hMLH1 gene in head and neck squamous cell carcinoma”. Otolaryngol Head Neck Surg 141 (4): 484?90. (2009). doi:10.1016/j.otohns.2009.07.007. PMID 19786217.
^ “Methylation profiling of archived non-small cell lung cancer: a promising prognostic system”. Clin. Cancer Res. 11 (12): 4400?5. (2005). doi:10.1158/1078-0432.CCR-04-2378. PMID 15958624.

次ページ

記事の検索

Size:52 KB
出典: フリー百科事典『ウィキペディア（Wikipedia）』
担当:undef